Adolorin Ibuforte 400 mg Dragees

Recall | Medicines | 30/09/2020

The marketing authorisation holder informed its customers on September 29, 2020 that a reduced release of the active substance was detected in the concerned batch.

Therefore, this batch will be recalled.

Name of the medicinal product Adolorin Ibuforte 400 mg Dragees
Marketing authorisation number(s) 1-24505
CIP code 3759576
Marketing authorisation holder Kwizda Pharma GmbH
Batch number(s) 001013
Classification of the recall 2
Depth of recall Pharmacies
BASG reference number INS-640.001-3330
Email

Further inquiry note